Natalie A. Brill, based in Sherman Oaks, CA, is an accomplished inventor with a remarkable portfolio of 19 patents. Her work primarily lies in the field of neuromodulation, where she harnesses cutting-edge technology and innovative methodologies to enhance pain therapy and spinal cord stimulation.

Latest Patents

Among her notable patents is the groundbreaking invention titled "Machine Learning to Optimize Spinal Cord Stimulation." This system employs a processor and memory device that utilizes patient metrics to inform a machine learning algorithm. The innovative algorithm searches for the optimal neuromodulation parameter set, designed to produce a non-regular waveform that varies across time and space, significantly enhancing the effectiveness of spinal stimulation procedures.

Another significant patent is focused on "Targeted Electro Stimulation Fields Based on Focal Dermatomal Coverage." This invention details a neuromodulation system equipped with an electrostimulator designed to stimulate target tissue, inducing paresthesia while concurrently collecting pain data and patient feedback. By calculating spatial correspondence between pain sites and paresthesia sites across dermatomes, the system optimizes stimulation field design for more effective pain therapy.

Career Highlights

Natalie A. Brill is currently affiliated with Boston Scientific Neuromodulation Corporation, where she leverages her innovative skills to develop transformative medical technologies. Her dedication to advancing neuromodulation therapies marks her as a leader in this pivotal field.

Collaborations

Throughout her career, Brill has collaborated with esteemed colleagues, including Rosana Esteller and Changfang Zhu. These collaborations have enabled the integration of diverse expertise, enhancing the development of her innovative projects.

Conclusion

With her extensive experience and innovative contributions to neuromodulation technologies, Natalie A. Brill stands out as a pivotal figure in the field. Her patents not only demonstrate her commitment to improving patient outcomes but also exemplify the potential of technological advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.